Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging/Experiment 3

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-11-14

Curated date: 2024/03/22

Curator: Imaspecial

Revision editor(s): Imaspecial, Fiddyhamma

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
HIV infection [X]Human immunodeficiency virus disease,[X]Human immunodeficiency virus disease (disorder),[X]Unspecified human immunodeficiency virus [HIV] disease,[X]Unspecified human immunodeficiency virus [HIV] disease (disorder),HIV - Human immunodeficiency virus infection,HIV INFECT,HIV Infection,HIV infection,HIV Infections,HIV infectious disease,HTLV III INFECT,HTLV III Infections,HTLV III LAV INFECT,HTLV III LAV Infections,HTLV WIII INFECTIONS,HTLV WIII LAV INFECTIONS,HTLV-III Infection,HTLV-III Infections,HTLV-III-LAV Infection,HTLV-III-LAV Infections,HUMAN IMMUNO VIRUS DIS,human immunodeficiency virus,Human immunodeficiency virus [HIV] disease,HUMAN IMMUNOdeficiency VIRUS [HIV] INFECTION,Human immunodeficiency virus caused disease or disorder,Human immunodeficiency virus disease,Human immunodeficiency virus disease (disorder),Human immunodeficiency virus disease or disorder,Human immunodeficiency virus infection,Human immunodeficiency virus infection (disorder),Human immunodeficiency virus infection, NOS,Human immunodeficiency virus infectious disease,human immunodeficiency virus infectious disease,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,LYMPHOTROPIC VIRUS TYPE III INFECTIONS HUMAN T,T LYMPHOTROPIC VIRUS TYPE III INFECT HUMAN,T Lymphotropic Virus Type III Infections, Human,T-Lymphotropic Virus Type III Infections, Human,Unspecified human immunodeficiency virus [HIV] disease (disorder),hIV infection
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Controls/ People living without HIV (PLWOH)
Group 1 name Corresponds to the case (exposed) group for case-control studies
People living with HIV on Antiretroviral Therapy (PLWH on ART)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
People with HIV infection on Anti-Retroviral Therapy(ART)
Group 0 sample size Number of subjects in the control (unexposed) group
23
Group 1 sample size Number of subjects in the case (exposed) group
25

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V1-V2
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Linear Regression
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Matched on Factors on which subjects have been matched on in a case-control study
age, body mass index, ethnic group, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
unchanged
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-11-14

Curated date: 2024/03/22

Curator: Imaspecial

Revision editor(s): Imaspecial, Fiddyhamma

Source: Fig 4D

Description: Log-scale differences in bacterial abundance across feces (circle) between PLWOH and PLWH on ART.

Abundance in Group 1: increased abundance in People living with HIV on Antiretroviral Therapy (PLWH on ART)

NCBI Quality ControlLinks
Catenibacterium
Prevotella sp.
Alloprevotella
Lachnospiraceae

Revision editor(s): Imaspecial, Fiddyhamma

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-11-14

Curated date: 2024/03/22

Curator: Imaspecial

Revision editor(s): Imaspecial, Fiddyhamma

Source: Fig 4D

Description: Log-scale differences in bacterial abundance across feces (circle) between PLWOH and PLWH on ART.

Abundance in Group 1: decreased abundance in People living with HIV on Antiretroviral Therapy (PLWH on ART)

NCBI Quality ControlLinks
uncultured Erysipelotrichaceae bacterium
Alistipes
Peptostreptococcaceae
Bacteroides
Ruminococcus gauvreauii

Revision editor(s): Imaspecial, Fiddyhamma